|
|
|
04.08.25 - 20:09
|
Peanut Allergy Pipeline Market Insights Report 2025 | DBV712, PVX-108 & INP20 Lead the Way - ResearchAndMarkets.com (Business Wire)
|
|
|
DUBLIN--(BUSINESS WIRE)--The "Peanut Allergy - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering.
The "Peanut Allergy - Pipeline Insight, 2025" report delivers in-depth analysis of the Peanut Allergy therapeutic landscape, highlighting over 10 companies and upwards of 12 pipeline drugs.
This report encompasses detailed drug profiles across clinical and nonclinical stages, with assessments categorized by product type, stage, route of administration, and molecule type. Moreover, it touches on inactive pipeline products, providing a comprehensive view of the current scenario and future growth prospects in Peanut Allergy treatments.
Peanut allergy is a significant focus due to its prevalence and potential severity, often leading to severe reactions such as anaphylaxis. Although strict eradication of peanuts from the diet is advised, the pervasive presence of trace peanut residues makes total avoidance difficult, propelling the need for research toward innovative therapies. Immunothe...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
04.03.25 - 08:03
|
Stallergenes Greer Announces Appointment of Andreas Amrein as Chief Executive Officer (Business Wire)
|
|
|
BAAR, Switzerland--(BUSINESS WIRE)--Stallergenes Greer, a global leader in allergy therapeutics, today announced that the Board of Directors has appointed Andreas Amrein as Chief Executive Officer, with effect from April 1, 2025. After more than 10 years with the company, Michele Antonelli is retiring and will step down from his role as Chief Executive Officer at the end of March 2025.
“We are delighted to welcome Andreas Amrein as Chief Executive Officer of Stallergenes Greer. He joins our company at a time of strong opportunity for continued expansion and development within allergy therapeutics, building on the excellent platform of capabilities within the firm. Andreas is a dynamic business leader with a proven track record of driving growth. His strategic vision, strong focus on execution and delivery, and extensive international experience will be key in leading Stallergenes Greer and its people through its next stage of development. We look forward to working with Andreas to realise Stallergenes G...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
